- pause slideshow
Low levels of the potentially harmful impurity N-nitrosodimethylamine have been detected in batches of valsartan produced by a second pharmaceutical company, the European Medicines Agency has learnt.
A paediatric trainee who was found guilty of gross negligence manslaughter after the death of a six-year-old boy from sepsis has won her appeal to be reinstated to the medical register and continue to practise as a doctor.
Direct oral anticoagulants carry lower risk of major bleeding versus warfarin, data showSubscription
Research from primary care suggests apixaban may be the safest of the direct oral anticoagulants overall.
A review published in the Canadian Medical Association Journal has backed up guidance stating that anticonvulsants are ineffective for treating lower back pain.
Researchers find that after five years of follow-up, more than half of people taking dopamine agonists for management of Parkinson’s disease developed impulse-control disorders.
Research has shown that giving patients personalised information about their disease risk can motivate them to make lifestyle changes.
A study of 258 men with otherwise untreatable prostate cancer shows that the rate of disease control or response lasting six months or more was 11%, with two patients showing complete response.
Sleep disruption is an important risk factor for developing atrial fibrillation, study results show.
With blockbuster biologic adalimumab coming off patent in October 2018, pharmacists should be ready to switch patients to the best value biologic as alternatives become available.
A solution developed to deliver clinical pharmacy services to remote dispensing GP practices in Scotland is being used as a model to expand telehealth services across the rest of NHS Highland.
Follow the latest updates on the proposed 12% funding cuts to community pharmacy, which could result in the closure of a quarter of pharmacies in England.
Pharmacists need answers now on FMDSubscription